UnicoCell

  • About
  • Cell Therapy
  • Products & services
  • News
  • Contact
  • 中文 / EN

Home > News > All News

News

    • Press Release
    • Events
All News
  • 2022-12-26 2022.12.26 UnicoCell received Acknowledgment letter of DMF (Drug Master File) from US FDA for its allogeneic cell bank

  • 2022-12-03 2022.12.3 UnicoVial was granted the winner at the National Innovation Award Ceremony

  • 2022-11-18 2022.12.1- 12.4 Visit UnicoCell @2022 Healthcare+ Expo Taiwan

  • 2022-11-09 2022.11.9 UnicoVial has won the 19th National Innovation Award held by Institute for Biotechnology and Medicine Industry

  • 2022-09-13 2022.9.13 UnicoCell has submitted an application to US FDA for a Phase III clinical trial of ELIXCYTE

  • 2022-09-01 2022.9.1 UnicoCell has submitted an application to Taiwan FDA for a Phase III clinical trial of ELIXCYTE

  • 2022-08-25 2022.8.25 UnicoCell was honored as the winner at the 4th GoldenBoat Award Ceremony

  • 2022-08-22 2022.8.22 The Ministry of Health and Welfare approved the application for the "Cell Process Unit" in cooperation with the Kaohsiung Chang Gung Memorial Hospital.

  • 2022-07-25 2022.7.22 UnicoCell has won GoldenBoat Awards held by General Chamber of Commerce of ROC and New Taipei City Government

  • 2022-07-20 2022.7.20 UnicoCell has completed recruiting patients for Phase II Clinical Trial of Chronic Kidney Disease

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
3 page / total 5
向榮生醫科技

11494 台北市內湖區民權東路六段13之20號5樓

Tel:886-2-2792-2699 FAX:886-2-2792-7890

E-Mail : info@unicocell.com

LinkedIn Facebook Line
Copyright © 2018-2025 向榮生醫科技股份有限公司